Incentive Programs for Female Substance Abusers Who Smoke - 3

This study is ongoing, but not recruiting participants.

First Received: July 15, 2003 Last Updated: May 23, 2008 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00064922

Purpose

The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.

Condition	Intervention	Phase
Tobacco Use Disorder	Behavioral: Behavior Therapy	Phase II Phase III

Study Type:	Interventional
Study Design:	Treatment, Active Control
Official Title:	Incentive Programs for Female Substance Abusers Who Smoke

Resource links provided by NLM:

MedlinePlus related topics: Smoking Smoking and Youth

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment:	90
Study Start Date:	January 2002
Estimated Study Completion Date:	May 2005

Detailed Description:

This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.

Eligibility

Ages Eligible for Study:	15 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol
Nicotine Dependent as confirmed by DSM-IV checklist
Current cigarette smoker
Breath CO reading of at least 8 ppm at the time of the initial study screening
Current client with the Shields for Families (Shields) treatment programs

Exclusion Criteria:

Non-smoker

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00064922

Locations

United States, California
Shields for Families, Inc.
Los Angeles, California, United States, 90061

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

Principal Investigator:

Leslie Amass, Ph.D.

Los Angeles Treatment Research Center

More Information

No publications provided

Study ID Numbers:	NIDA-13638-3, R01-13638-3
Study First Received:	July 15, 2003
Last Updated:	May 23, 2008
ClinicalTrials.gov Identifier:	NCT00064922 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Mental Disorders
Tobacco Use Disorder
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on November 09, 2009